Coverart for item
The Resource Handbook of cancer vaccines, edited by Michael A. Morse, Timothy M. Clay, H. Kim Lyerly

Handbook of cancer vaccines, edited by Michael A. Morse, Timothy M. Clay, H. Kim Lyerly

Label
Handbook of cancer vaccines
Title
Handbook of cancer vaccines
Statement of responsibility
edited by Michael A. Morse, Timothy M. Clay, H. Kim Lyerly
Title variation
Cancer vaccines
Contributor
Subject
Genre
Language
eng
Summary
The book is laid out into four sections including a Basic Science Background, General Vaccine and Immunotherapy Strategies, Tumor Specific Vaccines Being Developed and closing with a final section on General Background of Clinical Trials and Immune Analysis. The first section provides an overview of antigen processing, tumor antigen discovery, T cell activation, and augmenting the antigen-specific immune response. Section two progresses into a discussion of the different vaccination strategies currently under development. The third section includes chapters that introduce the reader to clinical trials in various malignancies. The final section in the book includes chapters discussing important issues in clinical trial design, analysis, and the regulatory requirements for bringing candidate vaccines through clinical trials and into clinical practice and use
Member of
Cataloging source
DNLM/DLC
Illustrations
illustrations
Index
index present
LC call number
RC271.I45
LC item number
H36 2004
Literary form
non fiction
Nature of contents
  • bibliography
  • handbooks
NLM call number
QZ266
NLM item number
.H2353 2004
http://library.link/vocab/relatedWorkOrContributorName
  • Morse, Michael A
  • Clay, Timothy M
  • Lyerly, H. Kim
Series statement
Cancer drug discovery and development
http://library.link/vocab/subjectName
  • Cancer vaccines
  • Cancer Vaccines
Label
Handbook of cancer vaccines, edited by Michael A. Morse, Timothy M. Clay, H. Kim Lyerly
Instantiates
Publication
Accompanying material
CD-ROM (3 3/4 in.).
Bibliography note
Includes bibliographical references and index
Carrier category
volume
Carrier category code
  • nc
Carrier MARC source
rdacarrier
Content category
text
Content type code
  • txt
Content type MARC source
rdacontent
Contents
  • Targeting viral antigens for the treatment of malignancies
  • Gretchen L. Eiben ... [et al.]
  • Immune defects in cancer patients
  • Dmitry Gabrilovitch and Vladimir Pisarev
  • Escape of tumors from the immune system : role of the transforming growth factor ßsignaling pathway
  • Gerard C. Blobe -- Immune adjuvants
  • Jory R. Baldridge, Susan L. Hand Zimmerman, and Sally P. Mossman
  • Heterologous prime-boost vaccination in tumor immunotherapy
  • Michael J. Palmowski and Caroline Smith
  • Peptide-based vaccines
  • Biology of the cancer vaccine immune response
  • Carmen M. Berger ... [et al.]
  • Antibody-inducing cancer vaccines against cell-surface carbohydrate antigens
  • Govind Ragupathi, John Gathuru, and Philip O. Livingston
  • Anti-idiotype vaccine
  • Sunil K. Chatterjee ... [et al.]
  • Pox viral vaccines
  • James L. Gulley, Philip M. Arlen, and Jeffrey Schlom
  • Utility of adenovirus-based vectors for multiple cancer vaccine approaches
  • Zachary Hartman and Andrea Amalfitano
  • Alphaviral-based strategies for the immunotherapy of cancer
  • Michael A. Morse, Timothy M. Clay, and H. Kim Lyerly
  • Edward L. Nelson and Jonathan Smith
  • DNA vaccines
  • Michael Bereta and Howard L. Kaufman
  • Whole cell vaccines
  • Timothy M. Clay ... [et al.]
  • Gene-modified tumor cell vaccines
  • Leisha A. Emens and Elizabeth M. Jaffee
  • Hapten-modified tumor vaccines
  • David Berd
  • Chaerone proteins/heat shock proteins as anticancer vaccines
  • The rational design of T cell epitopes with enhanced immunogenicity
  • Michael W. Graner and Emmanuel Katsanis
  • Dendritic cell vaccines
  • Madhav V. Dhodapkar
  • Exosomes for immunotherapy of cancer
  • Nathalie Chaput ... [et al.]
  • Immunocytokines for cancer immunotherapy
  • Paul M. Sondel and Stephen D. Gillies
  • T cell adoptive immunotherapy
  • Gregory E. Plautz ... [et al.]
  • Melanoma vaccines
  • John Fikes
  • Jeffrey Weber
  • Allogenic melanoma vaccines
  • Malcolm S. Mitchell
  • Renal cancer vaccines
  • Hyung L. Kim, Barbara J. Gitlitz, and Robert A. Figlin
  • Vaccines for hematologic malignancies
  • Qing Yi
  • Vaccines for the immunotherapy of prostate cancer
  • Boris Minev and Michael L. Salgaller
  • Vaccine therapy for breast and ovarian cancers
  • Identification of tumor antigens using subtraction and microarrays
  • Susan E. Smith and Alison T. Stopeck
  • Vaccine therapy for gastrointestinal cancers
  • John L. Marshall
  • Vaccines for lung cancer
  • Michael A. Morse, Jennifer Garst, and Eric Toloza
  • Vaccines for other tumors
  • Michael A. Morse
  • Clinical trial designs for therapeutic vaccine studies
  • Richard Simon
  • Analysis of cellular immune responses in cancer vaccine trials
  • Jiangchun Xu
  • Timothy M. Clay ... [et al.]
  • Analysis of humoral immune responses in vaccine trials
  • Rajasekharan Somasundaram, Tianqian Zhang, and Dorothee Herlyn
  • Regulatory issues affecting tumor vaccines
  • Mark O. Thornton ... [et al.]
  • Tumor antigen discovery with T cells
  • Paul F. Robbins
Control code
52258675
Dimensions
27 cm +
Extent
xvii, 592 pages
Isbn
9781588292094
Isbn Type
(alk. paper)
Lccn
2003011110
Media category
unmediated
Media MARC source
rdamedia
Media type code
  • n
Other physical details
illustrations
System details
System requirements for accompanying CD-ROM: Adobe Reader 6.0 or later
Label
Handbook of cancer vaccines, edited by Michael A. Morse, Timothy M. Clay, H. Kim Lyerly
Publication
Accompanying material
CD-ROM (3 3/4 in.).
Bibliography note
Includes bibliographical references and index
Carrier category
volume
Carrier category code
  • nc
Carrier MARC source
rdacarrier
Content category
text
Content type code
  • txt
Content type MARC source
rdacontent
Contents
  • Targeting viral antigens for the treatment of malignancies
  • Gretchen L. Eiben ... [et al.]
  • Immune defects in cancer patients
  • Dmitry Gabrilovitch and Vladimir Pisarev
  • Escape of tumors from the immune system : role of the transforming growth factor ßsignaling pathway
  • Gerard C. Blobe -- Immune adjuvants
  • Jory R. Baldridge, Susan L. Hand Zimmerman, and Sally P. Mossman
  • Heterologous prime-boost vaccination in tumor immunotherapy
  • Michael J. Palmowski and Caroline Smith
  • Peptide-based vaccines
  • Biology of the cancer vaccine immune response
  • Carmen M. Berger ... [et al.]
  • Antibody-inducing cancer vaccines against cell-surface carbohydrate antigens
  • Govind Ragupathi, John Gathuru, and Philip O. Livingston
  • Anti-idiotype vaccine
  • Sunil K. Chatterjee ... [et al.]
  • Pox viral vaccines
  • James L. Gulley, Philip M. Arlen, and Jeffrey Schlom
  • Utility of adenovirus-based vectors for multiple cancer vaccine approaches
  • Zachary Hartman and Andrea Amalfitano
  • Alphaviral-based strategies for the immunotherapy of cancer
  • Michael A. Morse, Timothy M. Clay, and H. Kim Lyerly
  • Edward L. Nelson and Jonathan Smith
  • DNA vaccines
  • Michael Bereta and Howard L. Kaufman
  • Whole cell vaccines
  • Timothy M. Clay ... [et al.]
  • Gene-modified tumor cell vaccines
  • Leisha A. Emens and Elizabeth M. Jaffee
  • Hapten-modified tumor vaccines
  • David Berd
  • Chaerone proteins/heat shock proteins as anticancer vaccines
  • The rational design of T cell epitopes with enhanced immunogenicity
  • Michael W. Graner and Emmanuel Katsanis
  • Dendritic cell vaccines
  • Madhav V. Dhodapkar
  • Exosomes for immunotherapy of cancer
  • Nathalie Chaput ... [et al.]
  • Immunocytokines for cancer immunotherapy
  • Paul M. Sondel and Stephen D. Gillies
  • T cell adoptive immunotherapy
  • Gregory E. Plautz ... [et al.]
  • Melanoma vaccines
  • John Fikes
  • Jeffrey Weber
  • Allogenic melanoma vaccines
  • Malcolm S. Mitchell
  • Renal cancer vaccines
  • Hyung L. Kim, Barbara J. Gitlitz, and Robert A. Figlin
  • Vaccines for hematologic malignancies
  • Qing Yi
  • Vaccines for the immunotherapy of prostate cancer
  • Boris Minev and Michael L. Salgaller
  • Vaccine therapy for breast and ovarian cancers
  • Identification of tumor antigens using subtraction and microarrays
  • Susan E. Smith and Alison T. Stopeck
  • Vaccine therapy for gastrointestinal cancers
  • John L. Marshall
  • Vaccines for lung cancer
  • Michael A. Morse, Jennifer Garst, and Eric Toloza
  • Vaccines for other tumors
  • Michael A. Morse
  • Clinical trial designs for therapeutic vaccine studies
  • Richard Simon
  • Analysis of cellular immune responses in cancer vaccine trials
  • Jiangchun Xu
  • Timothy M. Clay ... [et al.]
  • Analysis of humoral immune responses in vaccine trials
  • Rajasekharan Somasundaram, Tianqian Zhang, and Dorothee Herlyn
  • Regulatory issues affecting tumor vaccines
  • Mark O. Thornton ... [et al.]
  • Tumor antigen discovery with T cells
  • Paul F. Robbins
Control code
52258675
Dimensions
27 cm +
Extent
xvii, 592 pages
Isbn
9781588292094
Isbn Type
(alk. paper)
Lccn
2003011110
Media category
unmediated
Media MARC source
rdamedia
Media type code
  • n
Other physical details
illustrations
System details
System requirements for accompanying CD-ROM: Adobe Reader 6.0 or later

Library Locations

    • J. Otto Lottes Health Sciences LibraryBorrow it
      1 Hospital Dr, Columbia, MO, 65201, US
      38.939544 -92.328377
Processing Feedback ...